| Literature DB >> 35476704 |
Oh Joo Kweon1, Yong Kwan Lim1, Mi-Kyung Lee1, Hye Ryoun Kim1.
Abstract
BACKGROUND: The Sysmex DI-60 digital morphology analyzer is a fully automated, cell-locating image analysis system. This study aimed to evaluate the analytical performance of DI-60.Entities:
Mesh:
Year: 2022 PMID: 35476704 PMCID: PMC9045635 DOI: 10.1371/journal.pone.0267638
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Comparison of RBC morphology characterization between DI-60 and manual slide review with 291 peripheral blood smears.
| Agreement rate | Sensitivity, % (95% CI) | Specificity, % (95% CI) | Positive rate, % (N) | |||
|---|---|---|---|---|---|---|
| Total, % (95% CI) | ±1 grade | DI-60 | Manual or XN | |||
| Polychromasia | 93.8 (90.4–96.1) | 93.8 (90.4–96.1) | 100.0 (38.3–100.0) | 93.8 (90.3–96.1) | 7.2 (21/291) | 1.0 (3/291) |
| Hypochromia | 92.8 (89.2–95.3) | 93.5 (90.0–95.8) | 13.6 (3.9–34.2) | 100.0 (98.3–100.0) | 1.0 (3/291) | 7.6 (22/291) |
| Anisocytosis | 20.6 (16.4–25.7) | 27.8 (23.0–33.3) | 100.0 (93.5–100.0) | 6.3 (3.7–10.3) | 95.2 (277/291) | 23.0 (67/291) |
| Microcytosis | 96.2 (93.3–98.0) | 96.6 (93.7–98.2) | 9.1 (0.0–39.9) | 100.0 (98.4–100.0) | 0.3 (1/291) | 3.8 (11/291) |
| Macrocytosis | 47.8 (42.1–53.5) | 48.5 (42.1–54.2) | 100.0 (51.1–100.0) | 57.6 (41.8–53.3) | 53.3 (155/291) | 1.7 (5/291) |
| Target cells | 98.3 (95.9–99.9) | 98.6 (96.4–99.6) | 100.0 (51.1–100.0) | 98.6 (96.3–99.6) | 3.1 (9/291) | 1.7 (5/291) |
| Schistocytes | 28.9 (24.0–34.3) | 39.9 (34.4–45.6) | 97.2 (91.8–99.4) | 10.4 (6.7–15.7) | 92.4 (269/291) | 37.1 (108/291) |
| Spherocytes | 99.0 (96.9–99.8) | 99.0 (96.9–99.8) | 33.3 (5.6–79.8) | 100.0 (98.4–100.0) | 0 (0/291) | 1.0 (3/291) |
| Elliptocytes | 99.3 (97.4–99.9) | 99.3 (97.4–99.9) | 33.3 (5.6–79.8) | 100.0 (98.4–100.0) | 0.3 (1/291) | 1.0 (3/291) |
| Ovalocytes | 86.6 (82.2–90.1) | 86.9 (85.6–90.4) | 87.5 (62.7–97.7) | 86.9 (82.4–90.4) | 17.2 (50/291) | 5.5 (16/291) |
| Teardrop cells | 96.6 (93.7–98.2) | 96.9 (94.1–98.5) | 12.5 (0.1–49.2) | 99.3 (96.1–99.9) | 1.0 (3/291) | 2.8 (8/291) |
| Acanthocytes | 97.3 (94.6–98.7) | 97.3 (94.6–98.7) | N/A | 97.3 (94.6–98.7) | 2.8 (8/291) | 0 (0/291) |
Abbreviations: CI, confidence interval
†Within “mod/2+” and “many/3+” (except for schistocytes, within “few/1+” ~ “many/3+”).
‡For the parameters of cells with hypochromia (MCHC), anisocytosis (RDW), microcytosis (MCV), and macrocytosis (MCV), data from XN-20 were compared with those from DI-60 instead of manual slide review according to ICSH guidelines.
§N/A, not assessed due to lack of positive samples from manual slide review.
Assessment of repeatability and within-laboratory precision of DI-60 using peripheral blood smears with borderline results for abnormal RBC morphologies among 20 replicates.
| Mean, % | Repeatability, CV, % (95% CI) | Within-laboratory precision, CV, % (95% CI) | Result consistency | |
|---|---|---|---|---|
| Polychromatic cells | 3.94 | 18.3 (12.8–32.2) | 23.1 (16.9–36.4) | Neg~2+ |
| 6.22 | 24.6 (17.2–43.2) | 27.1 (20.5–40.1) | Neg~2+ | |
| 6.76 | 37.7 (26.3–66.1) | 41.4 (31.2–61.2) | Neg~2+ | |
| Target cells | 5.21 | 32.4 (22.6–56.8) | 38.6 (29.0–57.9) | Neg~2+ |
| Schistocytes | 0.42 | 80.8 (56.5–141.8) | 96.0 (72.0–143.9) | Neg~1+ |
| 0.67 | 27.1 (18.9–47.5) | 40.3 (29.2–65.0) | Neg~1+ | |
| 1.24 | 36.2 (25.3–63.5) | 38.7 (29.2–57.2) | Neg~1+ | |
| 1.55 | 44.8 (31.3–78.5) | 51.4 (38.9–76.1) | Neg~2+ | |
| 1.63 | 19.0 (13.3–33.3) | 23.7 (17.6–36.0) | Neg~2+ | |
| Spherocytes | 5.70 | 47.2 (33.0–82.8) | 55.1 (40.7–85.2) | Neg~2+ |
| Elliptocytes | 2.92 | 11.8 (8.2–20.6) | 12.9 (9.8–19.1) | Consistent |
| Ovalocytes | 3.74 | 18.7 (13.1–32.9) | 33.2 (23.8–54.8) | Neg~2+ |
| 7.49 | 21.4 (15.0–37.6) | 33.4 (24.2–53.8) | Neg~2+ | |
| Teardrop cells | 2.61 | 15.3 (10.7–26.9) | 19.7 (14.4–31.1) | Consistent |
| 4.14 | 18.1 (12.7–31.8) | 19.2 (14.5–28.3) | Neg~2+ | |
| 4.39 | 14.5 (10.1–25.4) | 17.1 (12.8–25.6) | Neg~2+ | |
| Acanthocytes | 3.19 | 58.5 (40.9–102.7) | 71.9 (53.6–109.5) | Neg~2+ |
| 6.50 | 26.5 (18.5–46.5) | 31.7 (23.8–47.5) | Neg~2+ | |
| Basophilic stippling | 3.83 | 31.8 (22.2–55.8) | 38.3 (28.3–59.3) | Neg~2+ |
| 5.30 | 28.5 (19.9–50.0) | 31.3 (23.6–46.2) | Neg~2+ |
Abbreviations: CV, coefficient of variation
†Near the cut-off value: 1% (0–2.0%) for schistocytes and 5% (2.5–7.5%) for others.
Comparison of white blood cell (WBC) and non-WBC differential counts between pre-classification by DI-60 and after verification by users.
| Verification | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pre-classification | Band (%) | Neu (%) | Lym (%) | Mono (%) | Eos (%) | Baso (%) | Promyel (%) | Myel (%) | Meta (%) | Blasts (%) | nRBCs (%) | Giant PLT (%) | Smudge (%) | Artifacts (%) | Kappa (95% CI) |
| Band (N = 7002 |
| 88.1 | 0.1 | 0.2 | 4.4 | 0.0 | 0.0 | 0.0 | 0.9 | 0.0 | 0.0 | 0.0 | 0.7 | 0.0 | 0.09 (0.07–0.11) |
| Neu (N = 115725) | 0.2 |
| 0.1 | 0.0 | 0.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | 0.0 | 0.88 (0.88–0.89) |
| Lym (N = 29762) | 0.0 | 0.0 |
| 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 3.6 | 0.0 | 0.94 (0.94–0.94) |
| Mono (N = 9099) | 0.2 | 1.3 | 0.6 |
| 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 5.4 | 0.0 | 0.86 (0.86–0.87) |
| Eos (N = 3621) | 0.0 | 2.1 | 0.0 | 0.0 |
| 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.1 | 0.6 | 0.0 | 0.78 (0.77–0.79) |
| Baso (N = 2199) | 0.2 | 4.8 | 19.8 | 0.4 | 0.5 |
| 0.0 | 0.4 | 0.5 | 0.2 | 0.0 | 0.1 | 9.5 | 0.1 | 0.75 (0.73–0.76) |
| Promyelo (N = 595) | 0.2 | 1.8 | 0.2 | 20.7 | 2.2 | 0.3 |
| 11.8 | 16.8 | 1.2 | 0.0 | 0.0 | 9.6 | 0.0 | 0.52 (0.47–0.57) |
| Myelo (N = 1914) | 1.2 | 8.9 | 11.9 | 3.7 | 4.2 | 0.7 | 0.1 |
| 23.6 | 0.5 | 0.0 | 0.5 | 2.8 | 0.0 | 0.56 (0.54–0.58) |
| Meta (N = 265) | 1.1 | 14.7 | 9.4 | 1.9 | 1.1 | 0.0 | 0.0 | 0.0 |
| 0.0 | 0.0 | 0.4 | 8.7 | 0.0 | 0.24 (0.19–0.28) |
| Blasts (N = 3593) | 0.0 | 0.0 | 13.1 | 10.7 | 0.0 | 0.0 | 0.5 | 1.3 | 2.0 |
| 0.0 | 0.0 | 1.5 | 0.1 | 0.81 (0.80–0.82) |
| nRBCs (N = 1547) | 0.0 | 0.1 | 2.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 |
| 3.3 | 0.6 | 1.9 | 0.94 (0.93–0.95) |
| Giant PLT (N = 9981) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| 0.3 | 0.1 | 0.99 (0.99–0.99) |
| Smudge (N = 9375) | 0.0 | 0.1 | 0.1 | 0.0 | 0.4 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 |
| 0.2 | 0.81 (0.80–0.81) |
| Artifacts (N = 3187) | 0.0 | 1.0 | 1.3 | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | 2.6 | 0.0 | 0.0 | 0.6 | 26.5 |
| 0.79 (0.77–0.80) |
| UnID (N = 6352) | 1.9 | 45.1 | 12.0 | 19.8 | 5.2 | 1.7 | 0.0 | 0.3 | 2.0 | 0.9 | 0.7 | 1.5 | 8.5 | 0.5 | - |
Abbreviations: Band, band neutrophils; Neu, neutrophils; Lym, lymphocytes; Mono, monocytes; Eos, eosinophils; Baso, basophils; Promyel, promyelocytes; Myel, myelocytes; Meta, metamyelocytes; nRBCs, normoblasts; Giant PLT, giant platelets; Smudge, smudge cells; UnID, unidentified
†Total cell count
Comparison of WBC and normoblast differential counts between DI-60 (after user verification) and manual slide review.
| Cells | Median value, % (IQR) | Mean difference, % (95% CI) | Spearman’s rank test | |||
|---|---|---|---|---|---|---|
| Manual | DI-60 |
| rs |
| ||
| Neutrophils | 66.5 | 69.4 | 0.01 | 2.76 | 0.96 | <0.01 |
| Lymphocytes | 18.5 | 17.0 | 0.07 | -1.22 (-3.21 to 0.77) | 0.94 | <0.01 |
| Monocytes | 6.5 | 5.2 | <0.01 | -1.51 | 0.76 | <0.01 |
| Eosinophils | 1.5 | 1.1 | 0.38 | 0.12 (-0.59 to 0.85) | 0.87 | <0.01 |
| Basophils | 0.0 | 0.5 | <0.01 | 0.27 | 0.37 | <0.01 |
| Immature granulocytes | 0.0 | 0.0 | 0.03 | 0.14 | 0.76 | <0.01 |
| Blasts | 0.0 | 0.0 | 0.48 | -0.82 | 0.63 | <0.01 |
| Atypical lymphocytes | 0.0 | 0.0 | 0.04 | 0.10 (0.03–0.17) | 0.44 | <0.01 |
| Normoblasts | 0.0 | 0.0 | <0.01 | -0.57 | 0.46 | <0.01 |
Abbreviations: IQR, interquartile range; CI, confidence interval
†Including band neutrophils.
‡Including metamyelocytes, myelocytes, and promyelocytes.
Total assay time and hands-on time comparison between DI-60 and manual slide review with 10 peripheral blood smears made from abnormal blood samples.
| Sample no. | WBCs | RBCs | Assay time | |||||
|---|---|---|---|---|---|---|---|---|
| Absolute count (Neu-Lym-Mono %) | Other findings | Hb (MCV-MCHC-RDW) | nRBCs | DI-60 | Manual Hands-on time | |||
| Analysis | Hands-on time | Total | ||||||
| 1 | 13260 (78-5-14-1) | IG (+) | 6.0 (78.2–34.9–19.9) | + | 221.6 (207–233) | 84.6 (62–104) | 306.2 (269–333) | 197.5 (190–205) |
| 2 | 34220 (86-2-9-1) | IG (+) | 7.3 (76.3–29.8–25.1) | + | 204.4 (197–209) | 69 (57–85) | 273.4 (259–294) | 185 (175–195) |
| 3 | 6670 (66-28-4-2) | - | 6.7 (131.3–35.4–19.8) | + | 207.4 (198–225) | 56.8 (46–80) | 264.2 (252–305) | 199 (191–207) |
| 4 | 4830 (75-16-5-1) | IG (+) | 9.9 (89.7–38.1–18.6) | + | 282.8 (261–305) | 91.8 (81–98) | 374.6 (342–400) | 243.5 (223–264) |
| 5 | 5400 (85-9-6-0) | - | 9.0 (93.0–30.9–19.9) | + | 237.2 (235–241) | 67.0 (57–91) | 303.8 (293–332) | 179.5 (168–191) |
| 6 | 4640 (51-37-8-4) | - | 6.4 (58.4–26.0–29.2) | - | 247.6 (228–259) | 66.2 (54–90) | 314.2 (285–350) | 211 (199–223) |
| 7 | 4670 (49-33-11-7) | - | 7.9 (114.4–31.1–19.3) | - | 252.2 (226–290) | 70.6 (62–83) | 322.8 (297–352) | 209.5 (205–214) |
| 8 | 2240 (15-68-16-0) | - | 13.6 (75.5–32.2–16.5) | - | 612.8 (580–662) | 94.4 (70–117) | 707.2 (665–748) | 332 (310–354) |
| 9 | 5470 (56-35-6-1) | - | 11.3 (90.5–33.0–17.1) | - | 340.6 (322–357) | 76.6 (72–81) | 417.2 (399–435) | 199 (189–209) |
| 10 | 17360 (69-14-12-1) | IG (+) Blasts (+) | 5.7 (103.4–31.1–22.3) | - | 206 (194–221) | 103.6 (84–129) | 309.6 (291–323) | 266 (260–272) |
| Total (consecutive | 2812.6 (2648–3002) | 780.6 (645–958) | 2645.8 (2553–2747) | 2222 (2110–2334) | ||||
Abbreviations: WBCs, white blood cells; RBCs, red blood cells; IG, immature granulocytes (metamyelocytes, myelocytes, and/or promyelocytes); Neu, neutrophils; Lym, lymphocytes; Mono, monocytes; Hb, hemoglobin; MCV, mean corpuscular volume; MCHC, mean corpuscular hemoglobin concentration; RDW, red cell distribution width
† Time interval from the slide input to the final report of the result.
‡Measured five times per slide.
§ Including 200 manual WBC differential counts performed by two well-trained medical technicians independently.
¶ User verification was performed immediately while another analysis was in progress.
Similarly, for all 10 normal samples, compared with manual slide review, DI-60 showed a longer total assay time but a considerably shorter hands-on time. The total assay time of DI-60 was 2411.2 s (2245–2596 s) including 410 s (404–464 s) of hands-on time, whereas that of manual slide review was 1856 s (1803–1909 s). The difference in the hands-on time between DI-60 and manual review was 1446 s (144.6 s/slide), similar to that required for abnormal samples.